Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Alpha Lipoic Acid vs Potassium: they're closely matched on evidence (7 vs 8.5/10); they're alternatives for support heart health — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Alpha Lipoic Acid and Potassium are closely matched across evidence, studies, and safety.
Verdict
Likely helps
8 of 10 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
2 of 3 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Alpha Lipoic Acid and Potassium have evidence — compare verdict strength side-by-side.
300-600mg
On empty stomach for best absorption, 30-60 minutes before meals
R-Alpha Lipoic Acid (R-ALA) — the natural form
Supplements commonly provide 99 mg per serving, and food provides more (no cited trial states the dose it used). No upper limit is established, so no maximum is stored. That is not a statement that larger amounts are safe.
With food to reduce GI upset, Spread throughout day, During/after exercise for athletes
Potassium Citrate or Potassium Gluconate
and 10 more not shown
4-12 weeks
4-8 weeks
2-4 weeks
2-4 weeks
1-2 weeks
Long-term
With excess or kidney issues
Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A Meta-Analysis and Systematic Review
Nutrients (2023) · Meta analysis · n=1242
ALA treatment produced favorable results for TSS (a dose-related trend was observed), NDS, and the global satisfaction score.
Effects of selected dietary supplements on migraine prophylaxis: A systematic review and dose-response meta-analysis of randomized controlled trials
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2025) · Meta analysis
Twenty-two trials were included in the systematic review and meta-analysis.
The Effect of Dietary Supplements on Male Infertility in Terms of Pregnancy, Live Birth, and Sperm Parameters: A Systematic Review and Meta-Analysis
Nutrients (2025) · Meta analysis
Systematic review and meta-analysis of 50 placebo-controlled trials of dietary supplements lasting at least 12 weeks in infertile men.
Effect of changes in potassium intake on blood pressure: a dose–response meta-analysis of randomized clinical trials (2000–2024)
Clinical Kidney Journal (2025) · Meta analysis
Our meta-analysis included 10 RCTs, comprising 4 studies on subjects without hypertension and 6 studies on subjects with hypertension.
Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length
Nutrients (2024) · Meta analysis
Both supplements demonstrated greater reductions in SBP for the general population at lower dosages and longer treatment durations.
Sex-specific associations between sodium and potassium intake and overall and cause-specific mortality: a large prospective U.S. cohort study, systematic review, and updated meta-analysis of cohort studies
BMC medicine (2024) · Meta analysis · n=416104
Prospective analysis of 237,036 men and 179,068 women in the NIH-AARP Diet and Health Study, plus an updated meta-analysis of cohort studies.
The points come from the SYDNEY 2 trial (PMID 17065669), which gave 181 people with diabetic polyneuropathy 600, 1,200 or 1,800 mg once daily or placebo for 5 weeks. All three doses beat placebo on the Total Symptom Score, with about the same size of effect: responder rates (a 50% or greater fall) were 62%, 50% and 56% against 26% on placebo, and effectiveness here is the responder rate above placebo. Nausea, vomiting and vertigo rose with dose, and the authors judged 600 mg once daily the best balance of benefit and risk. Doses below 600 mg were not tested. A 6-month trial of 1,200 mg a day in 200 patients (PMID 32370731) found benefit with mild nausea in 6 patients and no withdrawals, which is the basis for the 1,200 mg ceiling. A meta-analysis of 10 trials reported a dose-related trend in symptom scores (PMID 37630823), which the one head-to-head dose trial did not show.
AI-estimated from published studies. Interpret as directional guidance.
Both Alpha Lipoic Acid and Potassium are closely matched — the best choice depends on your specific health goals.
For support heart health, Potassium has a higher relevance score (68 vs 50).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.